Is my portfolio
One Report to Answer all your Questions!
Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1639.30
7.65 (0.47%) USFDA conducting inspection at Sun Pharma’s Mohali facility
Date: 12-09-2018The United States Food and Drug Administration (USFDA) is conducting an inspection at Sun Pharmaceutical Industries’ Mohali facility in state of Punjab. The inspection by the USFDA started on September 10, 2018 and is ongoing.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.